SPOP-mutant prostate cancer: Translating fundamental biology into patient care.

Abstract excerpt

Comprehensive cancer genome studies have revealed genetically-defined subtypes of prostate cancer with distinct truncal driver mutations. Because prostate cancer has been largely seen as a rather uniform disease, the clinical significance of this discovery remained largely obscure. However, recent findings imply distinct biological features and therapeutic vulnerabilities linked to specific truncal mutations....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clinical Decision-Making
• Share to Disease Management
• Share to Disease Susceptibility